Caprolactam Chemicals Ltd Stock Price Today (NSE: CAPRO)

Caprolactam Chemicals Ltd

46.50+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Caprolactam Chemicals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Caprolactam Chemicals Ltd share price today is 46.50, up +0.00% on NSE/BSE as of 22 September 2026. Caprolactam Chemicals Ltd (CAPRO) is a Small-cap company in the Commodity Chemicals sector with a market capitalisation of 21.39 (Cr). The 52-week high for CAPRO share price is 81.00 and the 52-week low is 37.10. At a P/E ratio of 52.44x, CAPRO is currently trading above its industry average P/E of 22.30x. The company has a Return on Equity (ROE) of 30.85% and a debt-to-equity ratio of 1.40.

Caprolactam Chemicals Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
53.30
Low
37.10
Volume
654.8571428571429
Change
+2.27%

Caprolactam Chemicals Ltd share price chart: 2.27% return over the past month. 52-week high ₹81.00, 52-week low ₹37.10.

Caprolactam Chemicals Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
46.5046.5046.4946.50400.00 (Cr)
46.5046.5046.5046.502.00 (Cr)
46.5546.5546.5546.551.00 (Cr)
46.6346.6346.6346.6364.00 (Cr)
48.9948.9946.6346.63123.00 (Cr)
49.0849.0849.0849.083.00 (Cr)
45.5049.0945.4849.09371.00 (Cr)
49.0949.1046.6946.771.56K (Cr)
53.3053.3049.0149.09121.00 (Cr)
50.6950.8250.0050.821.49K (Cr)

Caprolactam Chemicals Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
46.1353.3044.0846.50+0.80%
49.4549.9937.1043.94-11.14%
44.7051.5043.3747.88+7.11%
49.0451.4943.3444.70-8.85%
44.3155.5344.3049.04+10.67%
45.0558.4538.1046.57+3.37%
68.9868.9845.0545.05-34.69%
69.7272.8065.7172.61+4.15%
52.0881.0047.5173.38+40.90%
63.2669.0052.0852.08-17.67%
47.2060.2544.2560.25+27.65%
45.0046.9440.5045.15+0.33%

Returns & Performance

Excellent

Return on Equity (ROE)

30.85%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

49.87%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

33.90%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Caprolactam Chemicals Ltd Valuation Check

Poor

Price to Earnings (P/E)

52.44x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

22.30x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

54.50%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-373.41%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-81.67%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.85%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

22.04%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

22.04%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.40x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.01x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-4.84 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Caprolactam Chemicals Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of CAPRO across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Return on Equity (30.85%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (49.87%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (33.90%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Excellent EPS Growth (22.04% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (22.04% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Balanced Promoter Holding (54.50%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Premium Valuation Risk (P/E: 52.44x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-373.41%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-81.67%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

Elevated Debt Levels (D/E: 1.40)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Liquidity Concerns (Current Ratio: 0.39)

Observation: Current assets may not adequately cover short-term liabilities.

Analysis: Current ratio <1.0 raises working capital concerns.

Negative Free Cash Flow (₹-4.84 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Caprolactam Chemicals Ltd vs Commodity Chemicals Peers

Peer Comparison - Commodity Chemicals

Compare Caprolactam Chemicals Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
65.6/100
47
₹21.39
52.4
Average
30.85%
Excellent
49.87%
Excellent
1.4
Average
22.04%
Excellent
10.85%
Good
0.00%
49.2/100
2520
₹74697.84
34.6
Average
0.00%
Poor
15.29%
Good
0.4
Excellent
9.70%
Good
13.45%
Good
0.32%
34.6/100
1358
₹17140.87
17.4
Average
11.27%
Average
12.57%
Average
0.8
Good
12.99%
Good
14.65%
Good
0.65%
16.3/100
603
₹15377.77
-8.86%
Poor
-3.24%
Poor
0.4
Excellent
2.85%
Average
7.41%
Good
1.58%
56.5/100
575
₹8446.62
8.1
Average
0.00%
Poor
10.62%
Average
0.0
Excellent
3.00%
Average
8.67%
Good
3.61%
56/100
3514
₹7010.03
103.6
Average
20.47%
Excellent
27.28%
Excellent
0.2
Excellent
32.34%
Excellent
36.90%
Excellent
0.18%
32.9/100
713
₹5232.97
78.8
Average
0.00%
Poor
1.58%
Poor
0.1
Excellent
12.40%
Good
2.66%
38.9/100
426
₹3927.50
7.6
Average
13.42%
Average
16.97%
Good
0.0
Excellent
7.70%
Good
1.11%
Average
2.75%
67.5/100
73
₹3609.71
22.0
Average
16.23%
Good
21.35%
Excellent
0.0
Excellent
19.92%
Excellent
14.48%
Good
0.63%
18.4/100
177
₹2796.83
0.00%
Poor
-3.82%
Poor
1.1
Average
2.14%
Average
0.00%
66.7/100
620
₹2427.57
32.3
Average
13.27%
Average
21.98%
Excellent
0.0
Excellent
23.80%
Excellent
17.52%
Excellent
0.23%

Caprolactam Chemicals Ltd PE Ratio History

Historical price-to-earnings ratio for CAPRO — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.43₹55.25128.5x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Caprolactam Chemicals Ltd Quarterly Performance

Latest quarterly metrics for CAPRO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-81.67%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-373.41%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.85%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

22.04%

Compounded annual net profit growth over 5 years

Caprolactam Chemicals Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for CAPRO — calculated from daily price history

76RSI 14
Overbought — RSI 76

Momentum is strong — price may be stretched. Watch for pullbacks.

SMA 50
47
▼ Price below SMA 50 — Short-term bearish
SMA 200
51
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
1K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Caprolactam Chemicals Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Caprolactam Chemicals Ltd (CAPRO) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Caprolactam Chemicals Ltd

Loading latest quarterly results...

About CAPRO (Caprolactam Chemicals Ltd)

Caprolactam Chemicals Ltd is a dynamic manufacturer and distributor entrenched within the Indian commodity chemical sector. Established in 1988 and headquartered in Mahad, India, C...APRO distinguishes itself through its focused production and distribution of specialized chemical compounds. The company’s core strength lies in its ability to deliver consistent quality and reliability to its customers, building lasting partnerships across diverse industrial applications. Operating with a lean and efficient organizational structure, CAPRO prioritizes responsiveness to market demands and agility in adapting its production processes. The company is driven by innovation and customer satisfaction, positioning itself as a preferred partner for businesses seeking reliable chemical solutions in India. CAPRO’s operations are not confined solely to manufacturing its own chemical products. A significant aspect of its business model includes providing specialized job work services, leveraging its production expertise and infrastructure to meet the bespoke requirements of other chemical companies. This service offering reflects CAPRO's commitment to optimizing resource utilization and expanding its reach within the chemical industry value chain. By offering comprehensive job work solutions, the company reinforces its position as a versatile and trusted partner, facilitating collaboration and efficiency across the sector. This diversification demonstrates CAPRO's ability to adapt and capitalize on opportunities beyond its primary product offerings. The company's journey began under a different identity, formerly known as Vamotiwala Chemicals Industries Limited, before rebranding to Caprolactam Chemicals Limited. This evolution underscores CAPRO’s strategic vision and its dedication to aligning its corporate identity with its core business focus. The name change reflects a pivotal moment in the company's history, signifying a shift toward specialized chemical production and a renewed commitment to excellence. The company continues to build upon its legacy, enhancing its capabilities to meet the evolving demands of the chemical market while maintaining its steadfast commitment to quality and customer satisfaction.

Company Details

Symbol:CAPRO
Industry:Commodity Chemicals
Sector:Commodity Chemicals

Key Leadership

Ms. Zaver Shankarlal Bhanushali
Chairperson & MD
Mr. Siddharth Shankarlal Bhanushali
Whole-time Director & CFO
Ms. Dolly Dipesh Shah
Company Secretary & Compliance Officer

CAPRO Share Price: Frequently Asked Questions

What is the current share price of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd (CAPRO) trades at ₹46.50 on NSE and BSE. Market cap ₹21.39 (Cr). Educational data only.

What is the P/E ratio of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has a P/E of 52.44x vs industry average 22.30x.

What is the Bull Run score for Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has a Bull Run score of 65.6/100 based on 25+ financial parameters.

Does Caprolactam Chemicals Ltd pay dividends?

Caprolactam Chemicals Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has ROE of 30.85%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Caprolactam Chemicals Ltd?

Caprolactam Chemicals Ltd has debt-to-equity of 1.40.

Is Caprolactam Chemicals Ltd a good investment?

Bull Run gives Caprolactam Chemicals Ltd a score of 65.6/100. This is not investment advice — consult a SEBI-registered advisor.